TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis

CD4+ CD25+ FoxP3+ regulatory T cells suppress cytotoxicity of CD8+ effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level

(2012) Kerstin Göbel et al.   Journal of Neuroinflammation

Denileukin diftitox: a novel immunotoxin

(2009) George Manoukian et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible

(2009) Yu-Hwa Huang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer

(2008) J. Yokokawa et al.   CLINICAL CANCER RESEARCH

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis by the Expansion of CD4+CD25+Regulatory T Cells

(2008) Su He Wang et al.   ENDOCRINOLOGY

NK cells and Treg cells: A fascinating dance cheek to cheek

(2008) Jacques Zimmer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development

(2008) Anne Grosse-Wilde et al.   JOURNAL OF CLINICAL INVESTIGATION

TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis

(2008) Niklas Finnberg et al.   JOURNAL OF CLINICAL INVESTIGATION